NCT00072007 - Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

March 31, 2003

Study Completion Date

October 31, 2010

Conditions

Leukemia

Interventions

BIOLOGICAL

filgrastim

BIOLOGICAL

rituximab

DRUG

CHOP regimen

DRUG

cladribine

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

prednisone

DRUG

vincristine sulfate

Trial Locations (11)

2000

Hopital des Cadolles, Neuchatel, Neuchâtel

4310

Praxis Dr. Beretta, Rheinfelden

5001

Kantonspital Aarau, Aarau

8038

Onkozentrum, Zurich

CH-6500

Oncology Institute of Southern Switzerland, Bellinzona

CH-3010

Inselspital Bern, Bern

CH-7000

Spitaeler Chur AG, Chur

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

CH-6000

Kantonsspital, Luzerne, Luzerne

CH-9007

Kantonsspital - St. Gallen, Sankt Gallen

CH-8091

UniversitaetsSpital Zuerich, Zurich

All Listed Sponsors

lead

Swiss Cancer Institute

OTHER